Akhila Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Akhila Drugs Private Limited

Akhila Drugs Private Limited, a struck off private limited company, was established on 28 March 2012 in Hyderabad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233TG2012PTC079982. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Bhaskara Rao Setti (Director), Vemula Swarna Kumari (Director), Vemula Vamsi Krishna (Director). It is based at No: 7-1-40/1, 203, Jamuna Tirtha Apartments Dharam Karan Road, Hyderabad, Telangana, 500016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TG2012PTC079982

  • Registration Number

    079982

  • Incorporation Date

    28 March 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 11 Months
Company report

Akhila Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Akhila Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Akhila Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Bhaskara Rao Setti Director 28 Mar 2012 Current
Vemula Swarna Kumari Director 28 Mar 2012 Current
Vemula Vamsi Krishna Director 28 Mar 2012 Current
Srinivasa Rao Yarlagadda Director 04 Apr 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Akhila Drugs.

Enhance accessibility to Akhila Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Akhila Drugs revenue growth over time
Akhila Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Akhila Drugs?

Unlock access to Akhila Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Akhila Drugs?

Unlock and access historical data on people associated with Akhila Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Akhila Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akhila Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Akhila Drugs
Recent Activity within the Organization
  • Director Appointment

    Srinivasa Rao Yarlagadda was appointed as a Director was appointed as a Director on 04 Apr 2012 & has been associated with this company since 13 years 10 months . was recorded as a recent event.

  • Director Appointment

    Bhaskara Rao Setti was appointed as a Director was appointed as a Director on 28 Mar 2012 & has been associated with this company since 13 years 11 months . was recorded as a recent event.

  • Director Appointment

    Vemula Swarna Kumari was appointed as a Director was appointed as a Director on 28 Mar 2012 & has been associated with this company since 13 years 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Vemula Vamsi Krishna was appointed as a Director was appointed as a Director on 28 Mar 2012 & has been associated with this company since 13 years 11 months . was completed.

  • Company Incorporation

    Akhila Drugs Private Limited was registered on 28 Mar 2012 with Roc Hyderabad & aged 13 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Akhila Drugs Private Limited?

The CIN of Akhila Drugs Private Limited is U24233TG2012PTC079982.

Where is Akhila Drugs Private Limited headquartered?

Akhila Drugs Private Limited is headquartered at No: 7-1-40/1, 203, Jamuna Tirtha Apartments Dharam Karan Road, Hyderabad, Telangana, 500016.

When was Akhila Drugs Private Limited incorporated?

Akhila Drugs Private Limited was incorporated on 28 March 2012.

Who are the current directors of Akhila Drugs Private Limited?

The current directors of Akhila Drugs Private Limited are

What is the primary industry of Akhila Drugs Private Limited?

The primary industry of Akhila Drugs Private Limited is Chemicals.

Is Akhila Drugs Private Limited a listed company?

Akhila Drugs Private Limited is unlisted.

What is the capital structure of Akhila Drugs Private Limited?

The authorized capital of Akhila Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available